Table 1 Baseline characteristics of the study population
Characteristics | Total (n = 30) |
|---|---|
Clinical characteristics | |
Age, year | 63.1 (6.6) |
Male Sex, n (%) | 24 (80) |
Weight, kg | 98.6 (18.0) |
BMI, kg/m2 | 32.0 (5.2) |
Waist, cm | 112.2 (10.9) |
Systolic blood pressure, mmHg | 142.7 (19.6) |
Diastolic blood pressure, mmHg | 79.7 (10.0) |
Heart rate, bpm | 68.6 (10.1) |
Risk factors | |
Smoker, n (%) | 14 (36) |
Hypertension, n (%) | 23 (77) |
Coronary artery disease | |
Previous MI, n (%) | 16 (53) |
Previous CABG, n (%) | 13 (43) |
Previous PCI, n (%) | 16 (53) |
Coronary stenosis, medical therapy only, n (%) | 2 (7) |
Biochemistry | |
Fasting blood glucose, mmol/l | 6.4 (1.4) |
HbA1C, % | 6.3 (0.5) |
LDL-cholesterol, mmol/l | 2.3 (0.7) |
eGFR, ml/min | 78.3 (11.5) |
Medication | |
Beta blockers, n (%) | 20 (67) |
Calcium antagonists, n (%) | 15 (50) |
ACE-I, ARB, n (%) | 20 (67) |
Statins, n (%) | 29 (97) |
Ivabradine, n (%) | 1 (3) |
Diuretics, n (%) | 10 (33) |
Aspirin, n (%) | 29 (97) |
Pre-study diabetes medication | |
Biguanide (metformin), n (%) | 12 (40) |
Sulfonylurea, n (%) | 1 (3.3) |
Diet and lifestyle therapy only, n (%) | 18 (60) |